Both hydroxylamine and nitroxide protect cardiomyocytes from oxidative stress.
The unique anti-oxidative activity of nitroxide radicals protecting against reactive oxygen-derived species (ROS) has been recently demonstrated in several model systems. The present study focuses on the activity of nitroxide and of its reduced form in cultured rat ventricular cardiomyocytes exposed to O2.- and H2O2 generated by hypoxanthine (HX) and xanthine oxidase (XO). To evaluate cell injury, spontaneous beating, leakage of lactate dehydrogenase (LDH), and depletion of cellular ATP were determined. The protective effect of 4-OH-2,2,6,6-tetramethyl-piperidine-N-oxyl (TPL) was compared with that of 4-OH-2,2,6,6-tetramethyl-1-hydroxypiperidine (TPL-H) and of several common anti-oxidants. A rapid exchange between TPL and TPL-H, is mediated by cellular metabolism and through reactions with ROS. In particular, TPL under O2.- flux is oxidized to oxo-ammonium cation (TPL+) which comproportionates with TPL-H yielding two nitroxide radicals. Because this exchange limits the distinction between the biological activities of TPL and TPL-H, NADH which can reduce TPL+ was included in order to maintain the nitroxide in its reduced form. The results demonstrate that both TPL and TPL-H protect cardiomyocytes against beating loss and LDH leakage. Conversely, cellular ATP depletion induced by HX/XO is inhibited by TPL-H, though not by TPL, suggesting that different mechanisms underlie their protective activities. Through a flip-flop between the two forms, which coexist in the system, the levels of TPL-H and TPL are continuously replenished. The conversion, upon reaction, of each antioxidant into the other one enables them, contrary to common antioxidants which operate in a stoichiometric mode, to act catalytically.
Zhang
R
R
Department of Molecular Biology, Hebrew University, Hadassah Medical School, Jerusalem, Israel.
Pinson
A
A
Samuni
A
A
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D002478:Cells, Cultured; D003497:Cyclic N-Oxides / Q000627:therapeutic use; D005609:Free Radicals; D006321:Heart / Q000187:drug effects*; D009206:Myocardium / Q000166:cytology; D009589:Nitrogen Oxides / Q000627:therapeutic use; D018384:Oxidative Stress / Q000187:drug effects*; D010880:Piperidines / Q000627:therapeutic use; D051381:Rats
C110289:4-hydroxy-2,2,6,6--tetramethylpiperidine-1-N-hydroxyl; D000975:Antioxidants; D003497:Cyclic N-Oxides; D005609:Free Radicals; D009589:Nitrogen Oxides; D010880:Piperidines